covid 19 News and Research

RSS

COVID-19 vaccines may reduce long-COVID symptoms

A new study describes the effectiveness of coronavirus disease 2019 (COVID-19) vaccines in reducing long-COVID symptoms.

8 Dec 2022

Exploring a variant-adapted SARS-CoV-2 recombinant protein vaccine

Researchers assessed the immunogenicity of a variant-adapted severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recombinant protein vaccine boosted with an AS03 adjuvant.

8 Dec 2022

What are the associations of metabolome, microbiome, and immune perturbations with severe COVID-19?

In a new study, researchers observed that coronavirus disease 2019 (COVID-19) progression and inflammatory responses are associated with changes in the metabolome and microbiome.

8 Dec 2022

Adult females exhibit impaired muscle and pulmonary function after COVID-19 recovery

In a new study, researchers examined muscle and pulmonary dysfunction during moderate exercise in adult females who recovered from coronavirus disease 2019 (COVID-19).

8 Dec 2022

Exploring COVID-19 vaccination prioritization strategies for primary and booster doses

Researchers evaluated the coronavirus disease 2019 (COVID-19) vaccine, prioritizing options for primary and booster doses.

8 Dec 2022

Study explores the risk of new-onset diabetes mellitus following SARS-CoV-2 infections

Researchers evaluated individuals who had SARS-CoV-2 infections and were diagnosed with diabetes mellitus within six months of the onset of COVID-19 to understand the temporal relationship between SARS-CoV-2 infections and diabetes mellitus.

8 Dec 2022

Booster COVID-19 mRNA vaccinations marginally increase the durability of neutralizing antibody responses

Researchers investigated the immunological mechanisms behind the decreasing efficacy of COVID-19 vaccines by evaluating the durability and magnitude of neutralizing antibodies and memory B and T cell responses to booster doses of mRNA COVID-19 vaccine.

8 Dec 2022

More states to consider extending postpartum Medicaid coverage beyond two months

A family death during the holidays prompts questions and reflection

It wasn't the Thanksgiving holiday any of us had expected. Two weeks before, my 94-year-old father-in-law, Melvin Zax, suffered a stroke after receiving dialysis and was rushed to a hospital near his residence in western New York.

8 Dec 2022

Buprenorphine prescription remained constant during the first year of COVID-19 pandemic

The number of active prescriptions for the opioid disorder treatment drug buprenorphine remained constant during the first year of the COVID-19 pandemic, but the number of new prescriptions for the treatment was far below what would normally have been expected, according to a new RAND Corporation study.

7 Dec 2022

Scientists develop new receptor “decoy” drug that potently neutralizes SARS-CoV-2 variants

Scientists at Dana-Farber Cancer Institute have developed a drug that potently neutralizes SARS-CoV-2, the COVID-19 coronavirus, and is equally effective against the Omicron variant and every other tested variant.

7 Dec 2022

UK's Newton Fund supported Mexican scientist to develop vaccines against Chikungunya, Zika and Dengue

Dr Arturo Reyes Sandoval is the Director of the National Polytechnic Institute, one of the largest and most prestigious universities in Mexico.

7 Dec 2022

Study identifies characteristics linked with higher likelihood of post COVID-19 condition diagnosis

Many studies have described a variety of long-term effects of COVID-19, with symptoms including fatigue and malaise, breathing difficulties, and cognitive problems, often referred to as post COVID-19 condition or long COVID.

7 Dec 2022

What was the SARS-CoV-2 seroprevalence among US adults during 2021 and 2022?

In a recent Morbidity and Mortality Weekly Report (MMWR), the United States Center for Disease Control and Prevention (U.S.-CDC) published the preliminary results of the National Health and Nutrition Examination Survey (NHANES) for August 2021–May 2022.

7 Dec 2022

Study reveals biological mechanism to explain why respiratory viruses spike in colder seasons

Researchers at Mass Eye and Ear and Northeastern University have discovered a previously unidentified immune response inside the nose that fights off viruses responsible for upper respiratory infections.

7 Dec 2022

Improved early detection and analysis of airborne pathogens with new liquid-coated air filters

Researchers from the University of Maine and University of Massachusetts Amherst have designed new liquid-coated air filters that allow for improved early detection and analysis of airborne bacteria and viruses, including the one that causes COVID-19.

7 Dec 2022

Researchers explore the correlation between the dynamic shedding pattern of SARS-CoV-2 and viral load

Researchers attempted to establish an association between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load, indicating its ribonucleic acid (RNA) levels, and the presence of infectious virions.

7 Dec 2022

What is the prevalence of pulmonary tissue injury among hospitalized COVID-19 patients?

Researchers identified risk factors for and the prevalence of persistent pulmonary tissue alterations among hospitalized coronavirus disease 2019 (COVID-19) patients.

7 Dec 2022

Air pollution-triggered immune surveillance deficits in the lungs increase the risk of respiratory diseases with aging

Researchers highlighted the significance of air quality in preserving immune health over the human lifespan, especially lung-related immunity, owing to the lungs' continuous exposure to the environment.

7 Dec 2022

Paxlovid has been free so far. Next year, sticker shock awaits.

Nearly 6 million Americans have taken Paxlovid for free, courtesy of the federal government. The Pfizer pill has helped prevent many people infected with covid-19 from being hospitalized or dying, and it may even reduce the risk of developing long covid.

7 Dec 2022

covid 19 News and Research

COVID-19 vaccines may reduce long-COVID symptoms

Exploring a variant-adapted SARS-CoV-2 recombinant protein vaccine

What are the associations of metabolome, microbiome, and immune perturbations with severe COVID-19?

Adult females exhibit impaired muscle and pulmonary function after COVID-19 recovery

Exploring COVID-19 vaccination prioritization strategies for primary and booster doses

Study explores the risk of new-onset diabetes mellitus following SARS-CoV-2 infections

Booster COVID-19 mRNA vaccinations marginally increase the durability of neutralizing antibody responses

More states to consider extending postpartum Medicaid coverage beyond two months

A family death during the holidays prompts questions and reflection

Buprenorphine prescription remained constant during the first year of COVID-19 pandemic

Scientists develop new receptor “decoy” drug that potently neutralizes SARS-CoV-2 variants

UK's Newton Fund supported Mexican scientist to develop vaccines against Chikungunya, Zika and Dengue

Study identifies characteristics linked with higher likelihood of post COVID-19 condition diagnosis

What was the SARS-CoV-2 seroprevalence among US adults during 2021 and 2022?

Study reveals biological mechanism to explain why respiratory viruses spike in colder seasons

Improved early detection and analysis of airborne pathogens with new liquid-coated air filters

Researchers explore the correlation between the dynamic shedding pattern of SARS-CoV-2 and viral load

What is the prevalence of pulmonary tissue injury among hospitalized COVID-19 patients?

Air pollution-triggered immune surveillance deficits in the lungs increase the risk of respiratory diseases with aging

Paxlovid has been free so far. Next year, sticker shock awaits.

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News